Results 191 to 200 of about 2,618,941 (299)

Do future healthcare professionals advocate for pharmacogenomics? A study on medical and health sciences undergraduate students. [PDF]

Front Pharmacol
Al-Suhail H, Omar M, Rubaeih M, Mubarak T, Koufaki MI, Kanaris I, Mounaged F, Patrinos GP, Saber-Ayad M.   +8 more
europepmc   +1 more source

Medical informatics in academic health science centers

Academic Medicine, 1992
openaire   +3 more sources

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Expectations of Katowice residents regarding the program assumptions of the European city of science Katowice 2024 in the field of medical and health sciences - questionnaire survey results. [PDF]

BMC Public Health
Piotr R, Krzysztof K, Ewa N, Katarzyna B, Klaudia A, Tomasz H.   +5 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Prevalence of bullying and its impact on self-esteem, anxiety and depression among medical and health sciences university students in RAS Al Khaimah, UAE. [PDF]

Heliyon
Ibrahim FM, Rashad Dabou EA, AbdelSamad S, Abuijlan IAM.   +3 more
europepmc   +1 more source

Open science policies of medical and health sciences journals before and during the COVID-19 pandemic: a repeat cross-sectional study

, 2022
Gardener AD, Hicks EJ, Jacklin C, Tan G, Cashin AG, Lee H, Nunan D, Toomey EC, Richards GC.   +8 more
europepmc   +1 more source

Practical points for brain-friendly medical and health sciences teaching. [PDF]

J Educ Health Promot, 2019
Ghanbari S, Haghani F, Akbarfahimi M.
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Bridging the Gaps: The Transformative Effect of Coronavirus Disease 2019 (COVID-19) on Preventive Measures Among Medical and Health Sciences College Students in Madinah, Saudi Arabia. [PDF]

Cureus
Babikir IH, Alamri AM, Alraddadi AA, Alhajuj MN, Alnakhle MM, Alhajuj HA, Alfahal MS, Elmuttalut M.   +7 more
europepmc   +1 more source